Which HCPCS Code Should I Use for Eovist MRI contrast?

Under construction: A new 'A' code?

Under construction: A new 'A' code?

Question: Which HCPCS code should I use to report Eovist MRI contrast?

Answer: You should verify the appropriate code with your payer, but the most likely option is A9579 (Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified [NOS], per ml).

Here’s why: HCPCS doesn’t currently offer a specific Eovist (gadoxetate disodium) code for physician claims. (Code C9246 [Injection, gadoxetate disodium, per ml] does describe Eovist, but HCPCS guidelines state that C codes “can only be reported for facility [technical] services.”)

Because you don’t have a specific HCPCS code for your physician claim, you should choose a “not otherwise specified” code. CIGNA Government Services, the Part B carrier for North Carolina, for example, lists Eovist on its “Not Otherwise Classified Drug” Part B Fee Schedule under Option 3.

Eovist, used specifically to detect lesions in the liver, is a gadolinium-based magnetic resonance contrast agent, making it a match for code A9579. Remember to include on the claim the drug’s name and exact dosage given.

Potential new code: Eovist had a spot on the April 2009 HCPCS Public Meeting agenda. There was a request for a specific code, and CMS’s preliminary decision was that it would create Axxxx (Injection, gadoxetate disodium, 1ml). We’ll keep you posted.

Don’t miss our special ‘back to basics’ audio training event for radiology coders!

Related articles:

  1. 64450 or 64421: Which Code to Tap for TAP Block?Question: What exactly is a “tap block,” and what code…
  2. Prevent Shot, Hydration, IVIG Code Denials With This 3-Step ChecklistIf you miss this CPT 2009 change, you’ll lose $21…
  3. Do I Use a Chemo Code for Zevalin Therapy?Question: When I looked up Zevalin, I found out it’s…

Share:

More Posts

ICD-10 Data: Does It Matter?

It is often argued that ICD-10 coding does nothing for the patient. Recently that point was made at the U.S. House Energy & Commerce Subcommittee on Health hearing “Examining ICD-10 Implementation” last week.

Read More »